#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    VEXAS syndrome Squamous cell carcinoma of the vulva Dementia Intracranial calcification Fungal infection Primary amyloidosis Gastroenteropancreatic neuroendocrine tumour disease Neuroendocrine tumour of the lung Transitional cell cancer of the renal pelvis and ureter Non-Hodgkin's lymphoma refractory Guillain-Barre syndrome Prophylaxis against transplant rejection Thalassaemia alpha B-cell small lymphocytic lymphoma KBG syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Diagnostics Hereditary hypophosphataemic rickets – Life with Disease Acute respiratory distress syndrome – Diagnostics Alport’s syndrome – Diagnostics Amyotrophic lateral sclerosis – Basic Information Marfan’s syndrome – Trials in Disease Ehlers-Danlos syndrome – Treatment Pemphigoid Mucopolysaccharidosis III Advanced systemic mastocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ponatinib Bintrafusp Alfa Ds-2325A Anidulafungin Lysine Acetate Hydralazine Hydrochloride Cefiderocol Azetukalner Mercaptopurine Ddcart‐Cd19 Sufentanil Varnimcabtagene Autoleucel Efpegerglucagon RNMB2 Prednisolone Sodium Phosphate Sultiame Rezafungin Acetate Gskvx000000009151 Tyra-300-B01 Linvoseltamab More therapies…

    Learn about Your Condition

    Endometrial cancer stage II Immune thrombocytopenia Hepatic neoplasm Vascular graft thrombosis Essential hypertension Glaucoma Laparotomy Hepatotoxicity Prostate cancer Anal cancer stage II Electrocorticogram Niemann-Pick disease Colitis ulcerative Uterine leiomyosarcoma Transitional cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Temozolomide and Lomustine Followed by Radiotherapy versus Standard Treatment in Patients with Newly Diagnosed Grade 2 or 3 Glioma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Lomustine
    • Procarbazine
    • Temozolomide
    Germany

  • Study comparing BCG and combination of BCG with electromotive mitomycin-C treatment in patients with high-risk non-muscle-invasive bladder cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mitomycin
    Finland

  • Comparing Buprenorphine/Naloxone and Methadone for Opioid Use Disorder in Patients with Chronic Pain: A Study on Reducing Opioid Misuse

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug use disorder
    • Pain
    Investigated Drugs:
    • Buprenorphine
    • Methadone Hydrochloride
    • Naloxone
    The Netherlands

  • Study on CD19+ Lymphoid Disease Using Genetically Modified T Cells for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia recurrent
    • Non-Hodgkin’s lymphoma refractory
    Investigated Drugs:
    • T Lymphocytes Transduced With A Rv-Sfg.cd19.Cd28.4-1Bbzeta Retroviral Vector
    Germany

  • Study of adalimumab and infliximab dose adjustment guided by fecal calprotectin monitoring in adolescents and young adults with Crohn’s disease or ulcerative colitis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Adalimumab
    • Infliximab
    Belgium The Netherlands Spain

  • Study of VX-121, Tezacaftor, and Deutivacaftor for Children Aged 1-11 with Cystic Fibrosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Deutivacaftor
    • Vanzacaftor
    • Elexacaftor
    Belgium Denmark France Germany Ireland The Netherlands +1
Previous Page
1 … 374 375 376 377 378 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!